SHELL ASSET MANAGEMENT CO - HALOZYME THERAPEUTICS INC ownership

HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 215 filers reported holding HALOZYME THERAPEUTICS INC in Q1 2020. The put-call ratio across all filers is 0.66 and the average weighting 0.3%.

Quarter-by-quarter ownership
SHELL ASSET MANAGEMENT CO ownership history of HALOZYME THERAPEUTICS INC
ValueSharesWeighting
Q1 2024$1,008
+218.0%
21,734
+153.1%
0.02%
+53.3%
Q4 2023$317
-25.6%
8,588
-23.0%
0.02%
-16.7%
Q3 2023$426
+4.2%
11,156
-1.7%
0.02%
+12.5%
Q2 2023$409
+19.2%
11,350
+26.3%
0.02%
+14.3%
Q1 2023$343
-33.1%
8,983
-0.3%
0.01%
-36.4%
Q4 2022$513
-99.9%
9,014
-16.7%
0.02%
+29.4%
Q3 2022$428,000
-15.1%
10,822
-5.6%
0.02%
+13.3%
Q2 2022$504,000
+57.0%
11,460
+42.6%
0.02%
+87.5%
Q1 2022$321,000
-13.5%
8,038
-12.9%
0.01%0.0%
Q4 2021$371,000
-0.8%
9,226
+0.5%
0.01%0.0%
Q3 2021$374,000
-14.0%
9,182
-4.1%
0.01%0.0%
Q2 2021$435,000
+74.0%
9,572
+59.4%
0.01%
+60.0%
Q1 2021$250,000
-55.4%
6,006
-54.3%
0.01%
-58.3%
Q4 2020$561,000
+62.6%
13,1460.0%0.01%
+50.0%
Q3 2020$345,000
-2.0%
13,1460.0%0.01%
-11.1%
Q2 2020$352,000
+47.3%
13,146
-1.1%
0.01%
+28.6%
Q1 2020$239,0000.0%13,291
-1.5%
0.01%
+40.0%
Q4 2019$239,000
+11.7%
13,493
-2.1%
0.01%0.0%
Q3 2019$214,000
-10.5%
13,788
-0.8%
0.01%0.0%
Q2 2019$239,000
+4.4%
13,906
-2.2%
0.01%0.0%
Q1 2019$229,00014,2240.01%
Other shareholders
HALOZYME THERAPEUTICS INC shareholders Q1 2020
NameSharesValueWeighting ↓
Third Security, LLC 19,816,162$195,784,0009.33%
BB BIOTECH AG 5,846,564$57,764,0002.74%
QVT Financial LP 4,556,090$45,014,0002.44%
Parametrica Management Ltd 29,578$292,0002.21%
SECTORAL ASSET MANAGEMENT INC 4,389,682$43,370,0001.84%
Belmont Global Advisors, Inc. 257,000$2,539,0001.83%
HARVEY CAPITAL MANAGEMENT INC 394,550$3,898,0001.40%
Lombard Odier Asset Management (USA) Corp 1,350,000$13,338,0000.70%
IRIDIAN ASSET MANAGEMENT LLC/CT 6,199,685$61,253,0000.63%
Callan Capital, LLC 199,230$1,968,0000.53%
View complete list of HALOZYME THERAPEUTICS INC shareholders